C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
C4 Therapeutics, a clinical-stage biopharmaceutical company specializing in targeted protein degradation, announced a grant of non-qualified stock options for 85,480 shares to a new employee as an inducement to join the company. The options will vest over four years and have an exercise price equal to the closing stock price on the grant date, in a…